Back

HDAC inhibition improves myofibrillar relaxation and metabolism in a feline model of HFpEF

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Translational research in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Markus Wallner

Medical University of Graz, Graz (Austria)

5 More presentations in this session

Presentation thumbnail
Role of BGP-15 treatment in hypertensive heart failure progression and mitochondrial protection
Ms O. Horvath (Pecs, HU)
Abstract Slides
Presentation thumbnail
A novel biased S1P1 agonist improves renal and cardiac functions in ZSF1 rats, a model of metabolic syndrome-associated Heart Failure with preserved Ejection Fraction
Doctor M. Evaristi (Chilly-Mazarin, FR)
Abstract
Presentation thumbnail
GLP-1(28-36) prevents progression of ischemic heart failure in mice
Doctor M. Siraj (Toronto, CA)
Abstract
Presentation thumbnail
The Phosphodiesterase 4D interacting protein averts volume overload- but not pressure overload-induced pathological myocardial remodeling
Doctor B. Mohamed (Goettingen, DE)
Abstract
Presentation thumbnail
Heart failure rescue by high fat diet in a porcine model of hibernated myocardium
Doctor J. Martinez Milla (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Translational research in heart failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources